E
Edward Kanfer
Researcher at Hammersmith Hospital
Publications - 86
Citations - 2886
Edward Kanfer is an academic researcher from Hammersmith Hospital. The author has contributed to research in topics: Transplantation & Autologous stem-cell transplantation. The author has an hindex of 30, co-authored 86 publications receiving 2683 citations. Previous affiliations of Edward Kanfer include Imperial College London & Imperial College Healthcare.
Papers
More filters
Journal ArticleDOI
Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia
Francesco Dazzi,Richard Szydlo,Charles Craddock,Nicholas C.P. Cross,Jaspal Kaeda,Andrew Chase,Eduardo Olavarria,F. Van Rhee,Edward Kanfer,J. F. Apperley,J. M. Goldman +10 more
TL;DR: The findings suggest that the incidence of GVHD associated with the EDR is low, not because the final cell dose is small, but because lymphocytes are administered over a considerable number of months.
Journal ArticleDOI
Early detection of BCR-ABL transcripts by quantitative reverse transcriptase–polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia
Eduardo Olavarria,Edward Kanfer,Richard Szydlo,Jaspal Kaeda,Katayoun Rezvani,Kate Cwynarski,Christopher Pocock,Francesco Dazzi,Charles Craddock,Jane F. Apperley,Nicholas C.P. Cross,John M. Goldman +11 more
TL;DR: The results suggest that quantitative RT-PCR performed early after SCT is useful for predicting outcome and may help to define the need for further treatment.
Journal ArticleDOI
When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood.
C Elliott,D Samson,S Armitage,M. P. A. Lyttelton,D. Mcguigan,R Hargreaves,C Giles,G. Abrahamson,Z. Abboudi,M Brennan,Edward Kanfer +10 more
TL;DR: The number ofCD34+ cells harvested in a single leukapheresis can be predicted by measurement of the preceding day peripheral-blood circulating CD34+ concentration, and on the basis of these data a table of probable CD34-cell yield has been constructed.
Journal ArticleDOI
Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.
Aristeidis Chaidos,Scott J. Patterson,Richard Szydlo,Mohammed Suhail Chaudhry,Francesco Dazzi,Edward Kanfer,Donald McDonald,David Marin,Dragana Milojkovic,Jiri Pavlu,John C. Davis,Amin Rahemtulla,Katy Rezvani,John M. Goldman,Irene Roberts,Jane F. Apperley,Anastasios Karadimitris +16 more
TL;DR: Higher doses of CD4(-) iNKT cells in PBSC grafts are associated with protection from aGVHD, and this effect could be harnessed for prevention of aGV HD.
Journal ArticleDOI
CD34 counts to predict the adequate collection of peripheral blood progenitor cells.
TL;DR: A number of surrogate markers of peripheral blood progenitor cells were analysed to identify a single test which could predict the optimum time to harvest, providing at least 2 × 106 CD34+ cells/kg patient body weight.